Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Kangtai Biological Products Co., Ltd.
  6. News
  7. Summary
    300601   CNE100002Q33

SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

(300601)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-09-26
30.91 CNY   +8.68%
08/28China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
RE
08/22UBS Adjusts Shenzhen Kangtai Biological Products' Price Target to 66 Yuan From 72.50 Yuan, Keeps at Buy
MT
08/18Shenzhen Kangtai Biological Products Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Kangtai Biological's 2021 Profit Surges 86% on Robust Sales

04/28/2022 | 08:54pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. 8.68% 30.91 End-of-day quote.-49.81%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) 0.00% 7.1768 Delayed Quote.12.01%
All news about SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
08/28China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
RE
08/22UBS Adjusts Shenzhen Kangtai Biological Products' Price Target to 66 Yuan From 72.50 Yu..
MT
08/18Shenzhen Kangtai Biological Products Co., Ltd. announces an Equity Buyback for CNY 200 ..
CI
08/18Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
CI
08/18Shenzhen Kangtai Biological Products Co., Ltd. authorizes a Buyback Plan.
CI
07/25Kangtai Biological Sees Up to 70% Profit Slump in H1
MT
05/27Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend for the Ye..
CI
05/23Shenzhen Kangtai Biological Products Co., Ltd. Approves Final Cash Dividend for the Yea..
CI
05/06UBS Adjusts Shenzhen Kangtai Biological Products' Price Target to 116 Yuan From 125 Yua..
MT
04/28Kangtai Biological's 2021 Profit Surges 86% on Robust Sales
MT
More news
Analyst Recommendations on SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
More recommendations
Financials
Sales 2022 4 302 M 599 M 599 M
Net income 2022 562 M 78,3 M 78,3 M
Net cash 2022 697 M 97,2 M 97,2 M
P/E ratio 2022 55,7x
Yield 2022 0,74%
Capitalization 34 634 M 4 826 M 4 826 M
EV / Sales 2022 7,89x
EV / Sales 2023 5,98x
Nbr of Employees 2 445
Free-Float 48,9%
Chart SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Shenzhen Kangtai Biological Products Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 30,91 CNY
Average target price 49,30 CNY
Spread / Average Target 59,5%
EPS Revisions
Managers and Directors
Xiang Miao President & Director
Hui Zhou Chief Financial & Accounting Officer
Wei Min Du Chairman
Zhi Yun Lu Chairman-Supervisory Board
Ke Ping Hu Independent Director
Sector and Competitors